SG11201610228RA - Methods and compositions of bile acids and salts for reduction of fat - Google Patents

Methods and compositions of bile acids and salts for reduction of fat

Info

Publication number
SG11201610228RA
SG11201610228RA SG11201610228RA SG11201610228RA SG11201610228RA SG 11201610228R A SG11201610228R A SG 11201610228RA SG 11201610228R A SG11201610228R A SG 11201610228RA SG 11201610228R A SG11201610228R A SG 11201610228RA SG 11201610228R A SG11201610228R A SG 11201610228RA
Authority
SG
Singapore
Prior art keywords
fat
salts
compositions
reduction
methods
Prior art date
Application number
SG11201610228RA
Inventor
Hyun Ho Jung
Gi Hyeok Yang
Junho Lee
Sujin Cho
Original Assignee
Medytox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medytox Inc filed Critical Medytox Inc
Publication of SG11201610228RA publication Critical patent/SG11201610228RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
SG11201610228RA 2014-06-27 2015-06-26 Methods and compositions of bile acids and salts for reduction of fat SG11201610228RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462017891P 2014-06-27 2014-06-27
PCT/IB2015/001646 WO2015198150A2 (en) 2014-06-27 2015-06-26 Methods and compositions of bile acids and salts for reduction of fat

Publications (1)

Publication Number Publication Date
SG11201610228RA true SG11201610228RA (en) 2017-01-27

Family

ID=54938884

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201610228RA SG11201610228RA (en) 2014-06-27 2015-06-26 Methods and compositions of bile acids and salts for reduction of fat

Country Status (13)

Country Link
US (2) US10729700B2 (en)
EP (1) EP3145515B1 (en)
JP (1) JP6437112B2 (en)
KR (3) KR102146667B1 (en)
CN (3) CN106470702A (en)
AU (3) AU2015278833B2 (en)
BR (1) BR112016030341A8 (en)
CA (1) CA2952179C (en)
MX (1) MX2016017063A (en)
NZ (1) NZ727407A (en)
RU (1) RU2662356C1 (en)
SG (1) SG11201610228RA (en)
WO (1) WO2015198150A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3584317T5 (en) 2012-01-12 2022-01-17 Endo Global Ventures CLOSTRIDIUM HISTOLYTICUM ENZYME
EP3145515B1 (en) * 2014-06-27 2023-07-05 Medytox Inc. Formulations comprising cholate and/or chenodeoxycholate for non-surgical removal of a localized fat deposit
IL301796A (en) * 2017-03-01 2023-05-01 Endo Ventures Ltd Method for assessing and treating cellulite
JP7227918B2 (en) 2017-03-28 2023-02-22 エンド ベンチャーズ リミテッド Improved methods of collagenase production
MX2019002289A (en) * 2017-04-21 2019-09-26 Ami Pharm Co Ltd Injectable composition for topical fat reduction without pain, edema, and side effects, and method for preparing same.
CA3070853C (en) * 2017-08-03 2023-01-03 Medytox Inc. Methods for preparing bile acids
KR101865562B1 (en) * 2017-11-03 2018-06-08 주식회사 펜믹스 Lipolytic composition containing phosphocholine derivatives
CN108663251A (en) * 2018-05-16 2018-10-16 绍兴文理学院 A kind of tumor lympha closes the processing method for sweeping flesh tissue sample
KR102064864B1 (en) * 2019-02-08 2020-01-10 (주)제테마 Topical injectable composition
KR102111346B1 (en) * 2019-08-20 2020-05-22 아영창 Aqueous composition with sodium deoxycholate having improved stability against precipitation
KR102513115B1 (en) 2020-12-18 2023-03-22 주식회사 레시텍 Composition for localized fat reduction comprising lithocholic acid
WO2023287260A1 (en) * 2021-07-16 2023-01-19 주식회사 스카이테라퓨틱스 Molecular assembly of bile acid or bile salt and pharmaceutical composition comprising same for removing local fat
WO2023287261A1 (en) * 2021-07-16 2023-01-19 주식회사 스카이테라퓨틱스 Cosmetic composition comprising molecular aggregates of bile acids or bile acid salts

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
GB9417524D0 (en) 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
KR100848344B1 (en) 2000-02-04 2008-07-25 유서홍 Preparation of aqueous clear solution dosage forms with bile acids
US20050089555A1 (en) 2003-10-24 2005-04-28 Aventis Pharma Deutschland Gmbh Medicinal targeted local lipolysis
DE10349979B4 (en) * 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Drug targeted local lipolysis
US20050143347A1 (en) 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
WO2005117900A1 (en) * 2004-05-19 2005-12-15 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Use of a detergent for the non-surgical removal of fat
US20090221528A1 (en) * 2004-06-28 2009-09-03 Teresa Ann Denney Therapeutic micro nutrient composition for lipolysis and sclerosis
DE602005027727D1 (en) 2004-10-15 2011-06-09 Seo Hong Yoo COMPOSITIONS TO REDUCE THE TOXICITY OF CISPLATIN, CARBOPLATIN AND OXALIPLATIN
KR101469862B1 (en) * 2005-07-20 2014-12-08 주식회사 어가람닷컴 Vehicle user authentication device linked with mobile phone
US20070071706A1 (en) 2005-09-28 2007-03-29 Filiberto Zadini Lipodissolving dermatological topical preparation
KR100785656B1 (en) 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 Sodium glycocholate or derivatives thereof used as anti-inflammatory agents
US8242294B2 (en) * 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
CN101357119B (en) * 2007-08-01 2012-02-29 珠海清大弘瑞生物科技有限公司 Medicine microemulsion injection composition and preparation method thereof
JP4233056B1 (en) 2008-03-14 2009-03-04 株式会社木下製作所 Spheroidal graphite cast iron and method for producing the same
US20140113883A1 (en) * 2008-12-16 2014-04-24 James Robert DeLuze Therapeutic micro nutrient composition for lipolysis and sclerosis
US8101593B2 (en) * 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
DE102010028365A1 (en) 2010-04-29 2011-11-03 Lichtblick Gmbh Use of a phospholipid-containing composition for the removal of subcutaneous fat accumulations
ITMI20110534A1 (en) * 2011-03-31 2012-10-01 Prodotti Chimici Alimentari "NEW PROCESS FOR SELECTIVE OXIDATION OF BILE ACIDS, THEIR SALTS OR DERIVATIVES"
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US20130338200A1 (en) 2012-06-13 2013-12-19 MDM SpA Pharmaceutical dosage forms of tizanidine and administration routes thereof
EP3145515B1 (en) * 2014-06-27 2023-07-05 Medytox Inc. Formulations comprising cholate and/or chenodeoxycholate for non-surgical removal of a localized fat deposit
CA2872279C (en) * 2014-11-21 2018-06-12 Pankaj Modi Topical lipolysis compositions and methods

Also Published As

Publication number Publication date
US11517576B2 (en) 2022-12-06
US10729700B2 (en) 2020-08-04
AU2015278833A1 (en) 2017-01-05
KR101896087B1 (en) 2018-09-06
KR102146667B1 (en) 2020-08-21
WO2015198150A3 (en) 2016-04-21
AU2018260917A1 (en) 2018-11-29
CN114272251A (en) 2022-04-05
EP3145515A2 (en) 2017-03-29
US20200390787A1 (en) 2020-12-17
CN114224829A (en) 2022-03-25
EP3145515B1 (en) 2023-07-05
AU2020202081A1 (en) 2020-04-09
NZ727407A (en) 2018-12-21
BR112016030341A2 (en) 2017-08-22
AU2015278833B2 (en) 2018-12-06
AU2020202081B2 (en) 2021-02-25
KR20170003992A (en) 2017-01-10
JP6437112B2 (en) 2018-12-12
CA2952179C (en) 2019-01-08
KR20180098695A (en) 2018-09-04
JP2017519833A (en) 2017-07-20
CA2952179A1 (en) 2015-12-30
MX2016017063A (en) 2018-01-12
CN106470702A (en) 2017-03-01
KR102107831B1 (en) 2020-05-07
US20170136039A1 (en) 2017-05-18
WO2015198150A2 (en) 2015-12-30
BR112016030341A8 (en) 2021-07-20
KR20200026318A (en) 2020-03-10
EP3145515C0 (en) 2023-07-05
AU2018260917B2 (en) 2020-01-02
EP3145515A4 (en) 2018-02-07
RU2662356C1 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
HK1252688A1 (en) Methods for preparation of bile acids and derivatives thereof
SG11201610228RA (en) Methods and compositions of bile acids and salts for reduction of fat
ZA201707981B (en) Compositions of obeticholic acid and methods of use
IL251066B (en) Compositions and methods of use for treating metabolic disorders
ZA201700311B (en) Compositions and methods of use for treating metabolic disorders
IL256971A (en) Methods for preparation of bile acids and derivatives thereof
HUE055913T2 (en) Methods and compositions for diagnosis and treatment of glioblastoma
IL247529B (en) Lipoic acid choline ester compositions and methods of use
ZA201606199B (en) Compositions and methods for treating diabetes and liver diseases
IL246779A0 (en) Methods for the treatment and prevention of renal disorders and fatty liver disorders
IL249260A0 (en) Fatty acid bile acid conjugates for treatment of lipodystrophy
IL248210A0 (en) Methods and compositions for the treatment of vascular malformation
ZA201605109B (en) Compositions and methods for treating neutropenia
HK1225994A1 (en) Compositions for use in the treatment of allergic conditions
HK1243404A1 (en) Tryptamide compositions and methods of use
GB2561121B (en) Branched acid emulsifier compositions and methods of use
EP3206677A4 (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
HK1244782A1 (en) Compositions and methods for treating diseases and conditions
IL248494A0 (en) Methods and compositions for treatment of lipid storage disorders
HK1232209A1 (en) Method for the preparation of (s)-2-acetyloxypropionic acid and derivatives thereof (s)-2-
GB201408738D0 (en) Components and methods for formulation of components